[Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma]

A von Rohr1, T Cerny, R A Joss

  • 1Institut für Medizinische Onkologie, Universität, Inselspital Bern.

Schweizerische Medizinische Wochenschrift
|September 7, 1991
PubMed

Insights

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is common in small cell lung cancer patients, often presenting subtly. Early detection and tumor treatment are key to managing SIADH and may utilize antidiuretic hormone (ADH) as a tumor marker.

Area of Science:

  • Endocrinology
  • Oncology
  • Nephrology

Context:

  • Small cell lung cancer (SCLC) is a neuroendocrine tumor.
  • SCLC can ectopically produce peptide hormones, including antidiuretic hormone (ADH).
  • Paraneoplastic SIADH is a recognized complication of SCLC.

Purpose:

  • To review the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion (SIADH) in small cell lung cancer (SCLC).
  • To discuss the mechanisms, clinical presentation, incidence, and management of SIADH in SCLC patients.

Summary:

  • Paraneoplastic SIADH in SCLC can result from ectopic ADH production or other tumor-related mechanisms.
  • Clinically manifest SIADH occurs in approximately 4% of SCLC patients, with neurological symptoms due to cerebral edema.
  • Subclinical SIADH (hyponatremia, hypoosmolality, urine hyperosmolality) is more frequent (14%), with elevated ADH levels in 38% of patients.
  • Treatment involves addressing the underlying SCLC and fluid restriction; plasma ADH may serve as a tumor marker.

Impact:

  • Highlights the significant incidence of SIADH in SCLC, both overt and subclinical.
  • Emphasizes the role of ADH in SCLC pathogenesis and its potential as a tumor marker.
  • Informs clinical practice regarding the diagnosis and management of SIADH in SCLC patients.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...